Related Experiment Video
Updated: Mar 9, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Correlation study of basic Chinese medicine syndromes and neurotransmitter levels in patients with primary insomnia
Rong Zhang1, Yun-Shuang Yang2, Xiao-Chen Liu2
1Department of Medical Administration, General Hospital of the PLA Rocket Force, Beijing, 100088, China. rongzhangcn@163.com.
Objective:
To investigate the correlation between basic Chinese medicine (CM) syndromes (deficiency and excess syndromes) and intracranial neurotransmitter levels in primary insomnia (PI), to provide objective indicators and syndrome-based medical evidence for the differentiation of PI.
Methods:
A total of 158 patients with PI were recruited for CM syndrome differentiation. Another 30 healthy people without sleep disorders were selected as control group. An encephalofluctuograph analyzer was used to test the levels of intracranial neurotransmitters, including γ- aminobutyric acid (GABA), glutamate (Glu), 5-hydroxytryptamine (5-HT), dopamine (DA), etc., and their relevance were analyzed.
Results:
The neurotransmitter levels in the basic-deficiency group were lower than those in the healthy-control group, while the basic-excess group had higher levels than the healthy-control and basic-deficiency groups. Among the neurotransmitters, the 5-HT level was higher in the basic-excess group than in the basic-deficiency group (24.20±4.07 vs. 21.13±3.23; P<0.05); for the intermingled deficiency-excess group, the level of GABA was higher than that in the basic-deficiency group (9.48±3.07 vs. 7.23±3.67; P<0.05), Glu level was higher than that in the healthy-control group (7.53±4.10 vs. 5.83±0.99, P<0.05), and 5-HT and DA levels were lower than those in the healthy-control group (19.80±5.68 vs. 22.63±3.31, 5.27±3.79 vs. 6.83±1.58, respectively; P<0.05).
Conclusions:
There was a correlation between the basic syndromes and intracranial neurotransmitter levels in patients with PI, which could objectively reflect the CM differentiation in PI. This information could be important for improving CM diagnosis and treatment in PI.
More Related Videos
04:59Heat-sensitive Moxibustion as a Traditional Chinese Medicine Therapy for Chronic Obstructive Pulmonary Disease Combined with Insomnia
Published on: May 30, 2025
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Related Concept Videos
Management of Insomnia
Insomnia
Multiple factors contribute...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...